NO2013009I1 - Alipogen tiparvovec - Google Patents

Alipogen tiparvovec

Info

Publication number
NO2013009I1
NO2013009I1 NO2013009C NO2013009C NO2013009I1 NO 2013009 I1 NO2013009 I1 NO 2013009I1 NO 2013009 C NO2013009 C NO 2013009C NO 2013009 C NO2013009 C NO 2013009C NO 2013009 I1 NO2013009 I1 NO 2013009I1
Authority
NO
Norway
Prior art keywords
alipogen
tiparvovec
concerns
virus
baculovirus
Prior art date
Application number
NO2013009C
Other languages
English (en)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9497899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2013009(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO2013009I1 publication Critical patent/NO2013009I1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
NO2013009C 1996-11-22 2013-04-15 Alipogen tiparvovec NO2013009I1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614278A FR2756297B1 (fr) 1996-11-22 1996-11-22 Procede de production de virus recombinants
PCT/FR1997/002073 WO1998022607A1 (fr) 1996-11-22 1997-11-18 Procede de production de virus recombinants

Publications (1)

Publication Number Publication Date
NO2013009I1 true NO2013009I1 (no) 2013-04-29

Family

ID=9497899

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19992464A NO323937B1 (no) 1996-11-22 1999-05-21 Rekombinante hjelpe baculovirus samt fremgangsmate for fremstilling av rekombinante virus.
NO2013009C NO2013009I1 (no) 1996-11-22 2013-04-15 Alipogen tiparvovec

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19992464A NO323937B1 (no) 1996-11-22 1999-05-21 Rekombinante hjelpe baculovirus samt fremgangsmate for fremstilling av rekombinante virus.

Country Status (18)

Country Link
US (2) US6387670B1 (no)
EP (1) EP0946741B1 (no)
JP (1) JP4686670B2 (no)
KR (1) KR100719645B1 (no)
AT (1) ATE317908T1 (no)
AU (1) AU731106B2 (no)
BR (1) BR9713388B1 (no)
CA (1) CA2271438C (no)
CZ (1) CZ293947B6 (no)
DE (1) DE69735274T2 (no)
ES (1) ES2260803T3 (no)
FR (1) FR2756297B1 (no)
HU (1) HU224713B1 (no)
IL (1) IL129686A (no)
NO (2) NO323937B1 (no)
SK (1) SK286900B6 (no)
WO (1) WO1998022607A1 (no)
ZA (1) ZA9710516B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375119A1 (en) * 1999-05-27 2000-12-07 Genovo, Incorporated Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus
US6793926B1 (en) 1999-05-27 2004-09-21 Genovo, Inc. Methods for production of a recombinant adeno-associated virus
WO2000073424A1 (en) * 1999-05-28 2000-12-07 Mount Sinai School Of Medicine A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
GB9919409D0 (en) 1999-08-18 1999-10-20 Univ Oxford Brookes Baculovirus expression system
EP1572943B1 (en) 2002-08-29 2015-04-22 The Board of Trustees of The Leland S. Stanford Junior University Circular nucleic acid vectors, and methods for making and using the same
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
GB0702694D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Vectors
EP2019143A1 (en) 2007-07-23 2009-01-28 Genethon CNS gene delivery using peripheral administration of AAV vectors
EP2058401A1 (en) 2007-10-05 2009-05-13 Genethon Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
CN102006924B (zh) * 2008-03-05 2013-12-25 科学与工业研究委员会 聚合物杂化膜
EP2287323A1 (en) 2009-07-31 2011-02-23 Association Institut de Myologie Widespread gene delivery to the retina using systemic administration of AAV vectors
EP2292781A1 (en) 2009-08-17 2011-03-09 Genethon Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
EP2553105B1 (en) * 2010-04-01 2014-12-17 Weidong Xiao Compositions and methods for the production of recombinant virus vectors
JP2013523175A (ja) 2010-04-14 2013-06-17 イーエムディー・ミリポア・コーポレーション 高力価、高純度のウイルスストックの作製方法及びその使用方法
EP2847337A4 (en) 2012-05-09 2016-04-27 Univ Oregon Health & Science PLASMIDS AND VIRAL VECTORS ASSOCIATED WITH ADENOVIRUS
TWI702955B (zh) 2012-05-15 2020-09-01 澳大利亞商艾佛蘭屈澳洲私營有限公司 使用腺相關病毒（ａａｖ）ｓｆｌｔ-１治療老年性黃斑部退化（ａｍｄ）
WO2013190059A1 (en) 2012-06-21 2013-12-27 Association Institut De Myologie Widespread gene delivery of gene therapy vectors
EP3039129B1 (en) * 2013-08-30 2018-06-27 Amgen Inc. High titer recombinant aav vector production in adherent and suspension cells
CN112626125A (zh) 2014-03-17 2021-04-09 阿德夫拉姆生物技术股份有限公司 用于视锥细胞中增强的基因表达的组合物和方法
CA2978068A1 (en) 2015-03-02 2016-09-09 Adverum Biotechnologies, Inc. Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
GB2545763A (en) 2015-12-23 2017-06-28 Adverum Biotechnologies Inc Mutant viral capsid libraries and related systems and methods
CN111741760A (zh) 2017-11-27 2020-10-02 科达生物治疗医药有限公司 用于神经疾病的组合物和方法
US10610606B2 (en) 2018-02-01 2020-04-07 Homology Medicines, Inc. Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
US11306329B2 (en) 2018-02-19 2022-04-19 City Of Hope Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
JP2022523719A (ja) 2019-01-31 2022-04-26 オレゴン・ヘルス・アンド・サイエンス・ユニバーシティ Ａａｖキャプシドの転写依存性定方向進化を使用するための方法
JP2022545226A (ja) 2019-08-21 2022-10-26 コーダ バイオセラピューティクス， インコーポレイテッド 神経学的疾患のための組成物および方法
TW202140791A (zh) 2020-01-13 2021-11-01 美商霍蒙拉奇醫藥公司 治療苯酮尿症之方法
GB202013940D0 (en) 2020-09-04 2020-10-21 Synpromics Ltd Regulatory nucleic acid sequences
JP2023545731A (ja) 2020-10-07 2023-10-31 アスクレピオス バイオファーマシューティカル， インコーポレイテッド 肢帯型２ｉ（ｌｇｍｄ２ｉ）を含むジストログリカノパチー障害を処置するためのフクチン関連タンパク質（ｆｋｒｐ）の治療的アデノ随伴ウイルス送達
WO2023212293A1 (en) 2022-04-29 2023-11-02 Broadwing Bio Llc Complement factor h related 4-specific antibodies and uses thereof
WO2023212298A1 (en) 2022-04-29 2023-11-02 Broadwing Bio Llc Bispecific antibodies and methods of treating ocular disease
WO2023212294A1 (en) 2022-04-29 2023-11-02 Broadwing Bio Llc Angiopoietin-related protein 7-specific antibodies and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92298A (en) * 1988-11-14 2001-04-30 Us Secretary U S Dept Of Comme Method for producing isolated empty b19 parvovirus capsids, introducing genes into cells utilizing the same, diagnostic assays for detecting parvovirus infection and an anti-parvovirus vaccine containing said capsids
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
WO1996009074A1 (en) * 1994-09-23 1996-03-28 The General Hospital Corporation Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell

Also Published As

Publication number Publication date
FR2756297A1 (fr) 1998-05-29
IL129686A0 (en) 2000-02-29
CA2271438C (fr) 2010-10-26
HU224713B1 (en) 2006-01-30
ZA9710516B (en) 1998-06-10
EP0946741A1 (fr) 1999-10-06
ES2260803T3 (es) 2006-11-01
NO992464L (no) 1999-06-23
AU731106B2 (en) 2001-03-22
JP4686670B2 (ja) 2011-05-25
HUP0001762A3 (en) 2002-01-28
DE69735274T2 (de) 2006-10-12
JP2001503993A (ja) 2001-03-27
EP0946741B1 (fr) 2006-02-15
BR9713388B1 (pt) 2009-01-13
KR100719645B1 (ko) 2007-05-17
CZ293947B6 (cs) 2004-08-18
AU5226198A (en) 1998-06-10
NO992464D0 (no) 1999-05-21
WO1998022607A1 (fr) 1998-05-28
US20030022356A1 (en) 2003-01-30
SK66699A3 (en) 2000-02-14
DE69735274D1 (de) 2006-04-20
CZ182299A3 (cs) 1999-08-11
BR9713388A (pt) 2000-03-21
SK286900B6 (sk) 2009-07-06
HUP0001762A2 (hu) 2000-09-28
US6387670B1 (en) 2002-05-14
FR2756297B1 (fr) 1999-01-08
CA2271438A1 (fr) 1998-05-28
IL129686A (en) 2005-12-18
KR20000057202A (ko) 2000-09-15
NO323937B1 (no) 2007-07-23
ATE317908T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
NO2013009I1 (no) Alipogen tiparvovec
DE671419T1 (de) Herstellung von Polybutenen.
EE9800306A (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
DE69527924D1 (de) Hitzebeständige xylanasen
DK1489082T3 (da) Mellemprodukter
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
DE69534778D1 (en) Cathepsin-02-protease
ID18046A (id) Senyawa siklik campuran, pembuatan dan penngunaannya.
BR9507275A (pt) 1h-3-aril-pirrolidina-2,4-dionas alcoxi-alquil-substituídas
ZA98755B (en) Substituted hydroxy-anilino derivatives of cyclobutane-3,4-diones.
DE69811463T2 (de) Kompakter Festkörperlaser und Sender unter Verwendung desselben
ID24633A (id) Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
EA200000403A1 (ru) Новые соединения, полезные в качестве нейропротекторов
PE20399A1 (es) Muteina ob
ES2179908T3 (es) Acidos sacarosamonocarboxilicos acilados.
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması
SE9604093D0 (sv) Filter
TR27159A (tr) Sübstitüe edilmis 2 -fenil-5-(3-fenoksifelin (1,1,1-trifloropentanlari hazirlamaya mahsus yöntem ve aramaddeler.
ES1034145Y (es) Talonario autocopiativo de nuevas caracteristicas.
ID18287A (id) Fosforilamida, pembuatan dan penggunaannya
ES1035340Y (es) Expositor-contenedor de publicaciones.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application